CASI Pharmaceuticals (CASIF) Gross Margin Growth (1y) (2023 - 2025)
CASI Pharmaceuticals (CASIF) Gross Margin Growth (1y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -93.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -91.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 210.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1,966.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 228.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -475.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,672.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1,034.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CASI Pharmaceuticals | 2.65 Mn | -3.76 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,697.00 |
| Sep 30, 2025 | -2,895.00 |
| Jun 30, 2025 | -265.00 |
| Mar 31, 2025 | 502.00 |
| Dec 31, 2024 | -3,488.00 |
| Sep 30, 2024 | -682.00 |
| Jun 30, 2024 | -746.00 |
| Mar 31, 2024 | -655.00 |
| Dec 31, 2023 | -4,805.00 |
| Sep 30, 2023 | 31.00 |
| Jun 30, 2023 | 66.00 |
| Mar 31, 2023 | 76.00 |